Related Experiment Video
Updated: Jun 22, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases
Manishabrata Bhowmick1,2, Dorota Tokmina-Roszyk3, Lillian Onwuha-Ekpete3
1Torrey Pines Institute for Molecular Studies , 11350 SW Village Parkway, Port St. Lucie, Florida 34987, United States.
Researchers enhanced triple-helical peptide inhibitors (THPIs) for greater stability and selectivity against matrix metalloproteinases (MMPs). These improved MMP inhibitors showed efficacy in mouse models for multiple sclerosis and sepsis, demonstrating therapeutic potential.
Area of Science:
- Biochemistry
- Pharmacology
- Drug Discovery
Background:
- Designing selective matrix metalloproteinase (MMP) inhibitors with good solubility is challenging.
- Previous triple-helical peptide inhibitors (THPIs) were effective in vitro and water-soluble.
- Improvements in thermal stability and selectivity of THPIs were sought.
Purpose of the Study:
- To enhance the thermal stability and selectivity of first-generation THPIs.
- To evaluate the in vivo efficacy of redesigned THPIs in disease models.
Main Methods:
- Incorporation of non-native amino acids (Flp and mep) into THPIs to increase thermal stability.
- Development of THPIs with enhanced selectivity for specific MMPs.
- In vivo testing of THPIs in mouse models of multiple sclerosis and sepsis.
Main Results:
- A redesigned THPI selective for MMP-2 and MMP-9 showed an 18 °C increase in thermal stability and reduced disease severity in a mouse model of multiple sclerosis.
- A THPI targeting MMP-8 demonstrated efficacy in a mouse model of sepsis, minimizing lung damage and improving survival.
- This MMP-8 targeting THPI also increased anti-inflammatory cytokine IL-10 production.
Conclusions:
- Enhanced THPIs offer improved thermal stability and selectivity for targeting specific MMPs.
- Redesigned THPIs demonstrate significant therapeutic potential in preclinical models of inflammatory diseases.
- Further development of THPIs could lead to novel treatments for conditions involving MMP dysregulation.
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Role of Matrix Metalloproteases in Degradation of ECM
A...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

